Leber Congenital Amaurosis: A Guide for Parents

Receiving a diagnosis of Leber Congenital Amaurosis (LCA) for your child can feel like the world has suddenly shifted. It is completely normal to feel a sense of shock, grief, or overwhelm. While the diagnosis is serious, you are entering a community of dedicated specialists and families, supported by a field of medicine that is advancing more rapidly than ever before.

Understanding LCA

Leber Congenital Amaurosis (LCA) is a rare, severe, and early-onset form of inherited retinal dystrophy—a group of genetic conditions that affect the retina (the light-sensitive tissue at the back of the eye) ^[1][2]. LCA is one of the most common causes of blindness in children, occurring in approximately 2 to 3 out of every 100,000 live births ^[1][3].

In children with LCA, the retinal cells do not function correctly from birth or early infancy, leading to significant visual impairment ^[4]. However, “blindness” in LCA is often a spectrum; while vision loss is severe, many children retain some level of light perception or limited functional vision ^[5].

Early Signs and Behaviors

You may have noticed specific behaviors or physical signs that led to this diagnosis. These are common clinical markers of LCA:

• Nystagmus: This term refers to involuntary, rhythmic “wandering” or “shaking” of the eyes ^[2]. It happens because the brain is searching for a clear visual signal that the retina cannot provide.
• Nyctalopia: Commonly known as night blindness, this is a profound difficulty seeing in low-light environments ^[4].
• Oculo-digital Sign (Franceschetti’s Sign): This is a hallmark behavior where a child frequently pokes, presses, or rubs their eyes with their fingers or knuckles ^[6].

The Oculo-Digital Reflex

The oculo-digital sign occurs because the child is attempting to stimulate the retina mechanically ^[7]. This pressure creates “phosphenes”—flashes of light or patterns that provide the brain with visual input it isn’t getting from the environment ^[6].

While this behavior is a natural response, doctors monitor it closely because chronic, forceful eye-pressing can lead to long-term physical changes:

• Keratoconus: A condition where the cornea (the clear front surface of the eye) thins and begins to bulge into a cone shape ^[8][9].
• Enophthalmos: The appearance of “deep-set” eyes, which can occur over time due to the loss of fat behind the eyeball from constant pressure ^[10].

Three Stabilizing Facts for Families

As you navigate these first steps, keep these three essential facts in mind:

1. Genetic testing is the “North Star” for treatment. LCA is not one single disease, but many, caused by mutations in over 25 different genes (such as CEP290, GUCY2D, and RPE65) ^[11][12]. Identifying your child’s specific gene is the most important step for understanding their prognosis and eligibility for treatments ^[13].
2. LCA is a primary target for gene therapy. This field is at the forefront of medical history. The first-ever FDA-approved gene therapy for an inherited disease (Luxturna) was developed specifically for the RPE65 type of LCA ^[14][NCT05906953]. Many other types are currently being studied in active clinical trials [NCT06891443][NCT07681778].
3. The rate of vision loss varies significantly by gene. While LCA is canonically a progressive condition, the rate of change varies wildly depending on the gene involved. In some types, like GUCY2D-related LCA, the physical structure of the retina can remain relatively preserved for many years, even if vision is low, which may provide a wider “window” for future therapies ^[15].

Your Resource Guide

This guide is designed to help you navigate every step of your child’s care. We recommend reading through the following sections to build a comprehensive understanding of the path ahead: